Neurol. praxi. 2021;22(5):352-357 | DOI: 10.36290/neu.2021.058

How can MRI help in diagnostics of movement disorders

MUDr. Juraj Maňkoš1, doc. MUDr. Matej Škorvánek, PhD.2, 3
1 Neurologické oddelenie, Nemocnica s poliklinikou Bardejov, Bardejov
2 Neurologická klinika, Lekárska fakulta, Univerzita P. J. Šafárika, Košice
3 Neurologická klinika, Univerzitná nemocnica L. Pasteura, Košice

Magnetic resonance imaging (MRI) is a standard part of the differential diagnostic process in movement disorders and is typically performed as the first diagnostic step after excluding drug-induced, toxic or functional origin of the disorder. This review discusses MRI findings which are rather typical for different movement disorders in combination with a specific clinical phenomenology divided into three subcategories: atypical parkinsonism, disorders associated with brain metal accumulation (iron, manganese and copper) and other movement disorders.

Keywords: MRI, parkinsonism, brain metal accumulation, Huntington's disease.

Received: August 9, 2021; Revised: August 9, 2021; Accepted: August 16, 2021; Prepublished online: August 16, 2021; Published: November 8, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maňkoš J, Škorvánek M. How can MRI help in diagnostics of movement disorders. Neurol. praxi. 2021;22(5):352-357. doi: 10.36290/neu.2021.058.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    LMm_References

    1. Agarwal S, Gilbert R. Progressive Supranuclear Palsy. 2020 Jul 26. In: StatPearls [online]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. PMID: 30252354.
    2. Brandsma R, van Egmond ME, Tijssen MAJ. Groningen Movement Disorder Expertise Centre. Diagnostic approach to paediatric movement disorders: a clinical practice guide. Dev Med Child Neurol 2021; 63(3): 252-258. Go to original source... Go to PubMed...
    3. Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, Hagerman RJ. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications. Int J Mol Sci 2020; 21(12): 4391. doi: 10.3390/ijms21124391. PMID: 32575683; PMCID: PMC7352421 Go to original source... Go to PubMed...
    4. Dusek P, Litwin T, Czlonkowska A. Wilson disease and other neurodegenerations with metal accumulations. Neurol Clin 2015; 33(1): 175-204. Go to original source... Go to PubMed...
    5. Fragoso DC, da Mota Gonçalves Filho AL, Pacheco FT, Barros BR, Littig IA, Hoffmann Nunes R, Júnior ACMM, da Rocha AJ. Imaging of Creutzfeldt-Jakob Disease: Imaging Patterns and Their Differential Diagnosis. RadioGraphics 2017; 37(1): 234-257. Go to original source... Go to PubMed...
    6. Charidimou A, Boulouis G, Greenberg SM, Viswanathan A. Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis. Neurology 2019; 93(24): e2192-e2202. Go to original source... Go to PubMed...
    7. Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmieć T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, Dušek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol 2019; 18(7): 631-642. Go to original source... Go to PubMed...
    8. Lai PH, Tien RD, Chang MH, Teng MM, Yang CF, Pan HB, Chen C, Lirng JF, Kong KW. Chorea-ballismus with nonketotic hyperglycemia in primary diabetes mellitus. AJNR Am J Neuroradiol 1996; 17(6): 1057-64.
    9. Lee JY, Yun JY, Shin CW, Kim HJ, Jeon BS. Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy. J. Neurol 2010; 257(12): 2065-70. Go to original source... Go to PubMed...
    10. Lee WH, Lee CC, Shyu WC, Chong PN, Lin SZ. Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol 2005; 26(9): 2238-42.
    11. Leehey MA. Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J. Investig. Med 2011; 57(8): 830-6. Go to original source... Go to PubMed...
    12. McColgan P, Tabrizi SJ. Huntington's disease: a clinical review. Eur J Neurol 2018; 25(1): 24-34. doi: 10.1111/ene.13413. Epub 2017 Sep 22. PMID: 28817209 Go to original source... Go to PubMed...
    13. Meissner WG, Fernagut PO, Dehay B, Péran P, Traon AP, Foubert-Samier A, Lopez Cuina M, Bezard E, Tison F, Rascol O. Multiple System Atrophy: Recent Developments and Future Perspectives. Mov Disord 2019; 34(11): 1629-1642. doi: 10.1002/mds.27894. Epub 2019 Nov 6. PMID: 31692132 Go to original source... Go to PubMed...
    14. Negi RS, Manchanda KL, Sanga S. Imaging of Huntington's disease. Medical journal, Armed Forces India 2014; 70(4): 386-8. Go to original source... Go to PubMed...
    15. Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M. A new MR imaging index for differentiation of progressive supranuclear palsy - parkinsonism from Parkinson's disease. Parkinsonism & related disorders 2018; 54: 3-8. Go to original source... Go to PubMed...
    16. Righini A, Antonini A, De Notaris R, Bianchini E, Meucci N, Sacilotto G, Canesi M, De Gaspari D, Triulzi F, Pezzoli G. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 2004; 25(6): 927-32
    17. Stabile A, Di Lazzaro V, Colosimo C, Piazza F, Ferrarese C, DiFrancesco JC. Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature. Neurol Neurochir Pol 2018; 52(1): 102-106. Go to original source... Go to PubMed...
    18. Stamelou M, Tuschl K, Chong WK, Burroughs AK, Mills PB, Bhatia KP, Clayton PT. Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. Mov Disord 2012; 27(10): 1317-22. Go to original source... Go to PubMed...
    19. Svetel M, Tomić A, Dragašević N, Petrović I, Kresojević N, Jech R, Urgošik D, Banjac I, Vitković J, Novaković I, Kostić VS. Clinical course of patients with pantothenate kinase-associated neurodegeneration (PKAN) before and after DBS surgery. J Neurol 2019; 266(12): 2962-2969. doi: 10.1007/s00415-019-09499-3. Epub 2019 Aug 29. PMID: 31463603. Go to original source... Go to PubMed...
    20. Tha KK, Terae S, Tsukahara A, Soma H, Morita R, Yabe I, Ito YM, Sasaki H, Shirato H. Hyperintense putaminal rim at 1.5 T: prevalence in normal subjects and distinguishing features from multiple system atrophy. BMC Neurol 2012; 12(39). Go to original source... Go to PubMed...
    21. Uttley L, Carroll C, Wong R, Hilton DA, Stevenson M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis 2020; 20(1): e2-e10. doi: 10.1016/S1473-3099(19)30615-2. PMID: 31876504. Go to original source... Go to PubMed...
    22. Zheng W, Chen L, Chen JH, Lin X, Tang Y, Lin XJ, Wu J, Lin ZM, Lin JY. Hemichorea Associated With Non-ketotic Hyperglycemia: A Case Report and Literature Review. Front Neurol 2020; 11: 96. doi: 10.3389/fneur.2020.00096. PMID: 32158423; PMCID: PMC7052123 Go to original source... Go to PubMed...
    23. Zhou Y. Hemichorea in nonketotic hyperglycemia: Putamenal and cerebellum lesion on MR imaging. World Journal of Neuroscience 2012; 02(02). Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.